BRPI0518239A2 - composiÇÕes farmacÊuticas espontaneamente dispersÍveis - Google Patents

composiÇÕes farmacÊuticas espontaneamente dispersÍveis

Info

Publication number
BRPI0518239A2
BRPI0518239A2 BRPI0518239-5A BRPI0518239A BRPI0518239A2 BR PI0518239 A2 BRPI0518239 A2 BR PI0518239A2 BR PI0518239 A BRPI0518239 A BR PI0518239A BR PI0518239 A2 BRPI0518239 A2 BR PI0518239A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
solid
spontaneously dispersible
dispersible pharmaceutical
room temperature
Prior art date
Application number
BRPI0518239-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Ping Li
Madhusudhan Pudipeddi
Alan Edward Royce
Sara Royce Hynes
Abu T M Serajuddin
Barbara Lueckel
Michael Ambuehl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0518239A2 publication Critical patent/BRPI0518239A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0518239-5A 2004-10-29 2005-10-27 composiÇÕes farmacÊuticas espontaneamente dispersÍveis BRPI0518239A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62334404P 2004-10-29 2004-10-29
US62334504P 2004-10-29 2004-10-29
PCT/US2005/039004 WO2006050123A1 (en) 2004-10-29 2005-10-27 Spontaneously dispersible pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0518239A2 true BRPI0518239A2 (pt) 2008-11-11

Family

ID=35876536

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518239-5A BRPI0518239A2 (pt) 2004-10-29 2005-10-27 composiÇÕes farmacÊuticas espontaneamente dispersÍveis

Country Status (9)

Country Link
US (1) US20080064760A1 (enExample)
EP (1) EP1807049A1 (enExample)
JP (1) JP2008518931A (enExample)
KR (1) KR20070069172A (enExample)
AU (1) AU2005302501A1 (enExample)
BR (1) BRPI0518239A2 (enExample)
CA (1) CA2578854A1 (enExample)
MX (1) MX2007005124A (enExample)
WO (1) WO2006050123A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2663558C (en) * 2006-09-26 2013-05-28 Samyang Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
PE20081443A1 (es) * 2006-12-05 2008-12-23 Novartis Ag Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas
WO2008092084A2 (en) 2007-01-26 2008-07-31 Centocor, Inc. Injectable non-aqueous suspension with high concentration of therapeutic agent
WO2011139899A2 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
BR9808656A (pt) * 1997-03-12 2000-05-23 Abbott Lab Sistemas binários hidrofìlicos para a administração de ciclosporina
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
AU2003295773A1 (en) * 2002-11-21 2004-06-18 Novacea, Inc. Treatment of liver disease with active vitamin d compounds

Also Published As

Publication number Publication date
EP1807049A1 (en) 2007-07-18
MX2007005124A (es) 2007-06-22
WO2006050123A1 (en) 2006-05-11
US20080064760A1 (en) 2008-03-13
KR20070069172A (ko) 2007-07-02
JP2008518931A (ja) 2008-06-05
CA2578854A1 (en) 2006-05-11
AU2005302501A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
BRPI0507342A (pt) sólidos supersaturados estabilizados de fármacos lipofìlicos
BRPI0515390A (pt) composição farmacêutica, compreendendo uma dispersão sólida com matriz polìmero, compreendendo uma fase contìnua de polidextrose e uma fase contìnua de um polìmero além da polidextrose
CY1109265T1 (el) Συνθεσεις που συμπεριλαμβανουν δροσπιρενονη μοριακα διασπαρμενη
EP1708719A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF 2,6-DIISOPROPYLPHENOL (PROPOFOL) AND THEIR USE
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
BR122012030846B8 (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma
BR0311764A (pt) Composição herbicida
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
BRPI0009299B8 (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
BRPI0518553A2 (pt) composiÇço farmacÊutica estÁvel, mÉtodo para estabilizaÇço de pelo menos um ingrediente farmaceuticamente ativo e mÉtodo de uso de celulose microcristalina silicificada
BRPI0418330A (pt) composições sólidas de drogas de solubilidade baixa e poloxámeros
AR050717A1 (es) Composiciones farmaceuticas
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
ATE506955T1 (de) Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
BR0214159A (pt) Sistema farmacêutico radiopaco de liberação prolongada
BRPI0518239A2 (pt) composiÇÕes farmacÊuticas espontaneamente dispersÍveis
BRPI0801239A2 (pt) uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
AR064104A1 (es) Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas
SE0000730D0 (sv) Lipid carrier
ATE485261T1 (de) Salicylsäurederivate
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
BRPI0520503A2 (pt) composições antiinflamatórias e métodos de uso
DK1952142T3 (da) Opløsningssammensætning til undersøgelse af lægemiddelopløselighed
BRPI0516224A (pt) produto alimentìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente alimentìcio bioativo de interesse, processo de preparação do mesmo, e, utilização de um produto alimentìcio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.